ID   WWP1_HUMAN              Reviewed;         922 AA.
AC   Q9H0M0; O00307; Q5YLC1; Q96BP4;
DT   20-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 162.
DE   RecName: Full=NEDD4-like E3 ubiquitin-protein ligase WWP1;
DE            EC=2.3.2.26;
DE   AltName: Full=Atrophin-1-interacting protein 5;
DE            Short=AIP5;
DE   AltName: Full=HECT-type E3 ubiquitin transferase WWP1;
DE   AltName: Full=TGIF-interacting ubiquitin ligase 1;
DE            Short=Tiul1;
DE   AltName: Full=WW domain-containing protein 1;
GN   Name=WWP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND 6), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Mammary cancer;
RX   PubMed=11779188; DOI=10.1006/bbrc.2001.6206;
RA   Flasza M., Gorman P., Roylance R., Canfield A.E., Baron M.;
RT   "Alternative splicing determines the domain structure of WWP1, a Nedd4
RT   family protein.";
RL   Biochem. Biophys. Res. Commun. 290:431-437(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, UBIQUITINATION OF SMAD2 AND
RP   TGFBR1, AND INTERACTION WITH SMAD7 AND TGIF.
RX   PubMed=15359284; DOI=10.1038/sj.emboj.7600398;
RA   Seo S.R., Lallemand F., Ferrand N., Pessah M., L'Hoste S., Camonis J.,
RA   Atfi A.;
RT   "The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target
RT   Smad2 for degradation.";
RL   EMBO J. 23:3780-3792(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 191-870, AND INTERACTION WITH WBP1;
RP   WBP2; SCNN1A; SCNN1B AND SCNN1G.
RC   TISSUE=Bone marrow, and Brain;
RX   PubMed=9169421; DOI=10.1074/jbc.272.23.14611;
RA   Pirozzi G., McConnell S.J., Uveges A.J., Carter J.M., Sparks A.B.,
RA   Kay B.K., Fowlkes D.M.;
RT   "Identification of novel human WW domain-containing proteins by
RT   cloning of ligand targets.";
RL   J. Biol. Chem. 272:14611-14616(1997).
RN   [7]
RP   INTERACTION WITH DRPLA, AND TISSUE SPECIFICITY.
RX   PubMed=9647693; DOI=10.1006/mcne.1998.0677;
RA   Wood J.D., Yuan J., Margolis R.L., Colomer V., Duan K., Kushi J.,
RA   Kaminsky Z., Kleiderlein J.J. Jr., Sharp A.H., Ross C.A.;
RT   "Atrophin-1, the DRPLA gene product, interacts with two families of WW
RT   domain-containing proteins.";
RL   Mol. Cell. Neurosci. 11:149-160(1998).
RN   [8]
RP   INTERACTION WITH PIII.
RX   PubMed=12450395; DOI=10.1021/bi020125b;
RA   Galinier R., Gout E., Lortat-Jacob H., Wood J., Chroboczek J.;
RT   "Adenovirus protein involved in virus internalization recruits
RT   ubiquitin-protein ligases.";
RL   Biochemistry 41:14299-14305(2002).
RN   [9]
RP   FUNCTION IN UBIQUITINATION OF TGFBR1; SMAD6 AND SMAD7, AND INTERACTION
RP   WITH SMAD1; SMAD2; SMAD3; SMAD5; SMAD6; SMAD7; TGFBR1; TGFBR2 AND
RP   SKIL.
RX   PubMed=15221015; DOI=10.1038/sj.onc.1207885;
RA   Komuro A., Imamura T., Saitoh M., Yoshida Y., Yamori T., Miyazono K.,
RA   Miyazawa K.;
RT   "Negative regulation of transforming growth factor-beta (TGF-beta)
RT   signaling by WW domain-containing protein 1 (WWP1).";
RL   Oncogene 23:6914-6923(2004).
RN   [10]
RP   AUTOUBIQUITINATION.
RX   PubMed=18724389; DOI=10.1038/onc.2008.288;
RA   Chen C., Zhou Z., Liu R., Li Y., Azmi P.B., Seth A.K.;
RT   "The WW domain containing E3 ubiquitin protein ligase 1 upregulates
RT   ErbB2 and EGFR through RING finger protein 11.";
RL   Oncogene 27:6845-6855(2008).
RN   [11]
RP   INTERACTION WITH SPG20.
RX   PubMed=19580544; DOI=10.1042/BJ20082398;
RA   Edwards T.L., Clowes V.E., Tsang H.T., Connell J.W., Sanderson C.M.,
RA   Luzio J.P., Reid E.;
RT   "Endogenous spartin (SPG20) is recruited to endosomes and lipid
RT   droplets and interacts with the ubiquitin E3 ligases AIP4 and AIP5.";
RL   Biochem. J. 423:31-39(2009).
RN   [12]
RP   ACTIVATION BY NDFIP1 AND NDFIP2, AND AUTOUBIQUITINATION.
RX   PubMed=19343052; DOI=10.1038/embor.2009.30;
RA   Mund T., Pelham H.R.;
RT   "Control of the activity of WW-HECT domain E3 ubiquitin ligases by
RT   NDFIP proteins.";
RL   EMBO Rep. 10:501-507(2009).
RN   [13]
RP   INTERACTION WITH ERBB4.
RX   PubMed=19561640; DOI=10.1038/onc.2009.162;
RA   Li Y., Zhou Z., Alimandi M., Chen C.;
RT   "WW domain containing E3 ubiquitin protein ligase 1 targets the full-
RT   length ErbB4 for ubiquitin-mediated degradation in breast cancer.";
RL   Oncogene 28:2948-2958(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 546-917, MUTAGENESIS OF
RP   GLU-614; HIS-621; ASP-675; GLU-798; MET-804; GLU-806; ARG-845; GLN-848
RP   AND ARG-855, AND FUNCTION.
RX   PubMed=12535537; DOI=10.1016/S1097-2765(02)00774-8;
RA   Verdecia M.A., Joazeiro C.A.P., Wells N.J., Ferrer J.-L., Bowman M.E.,
RA   Hunter T., Noel J.P.;
RT   "Conformational flexibility underlies ubiquitin ligation mediated by
RT   the WWP1 HECT domain E3 ligase.";
RL   Mol. Cell 11:249-259(2003).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from
CC       an E2 ubiquitin-conjugating enzyme in the form of a thioester and
CC       then directly transfers the ubiquitin to targeted substrates.
CC       Ubiquitinates ERBB4 isoforms JM-A CYT-1 and JM-B CYT-1, KLF2, KLF5
CC       and TP63 and promotes their proteasomal degradation. Ubiquitinates
CC       RNF11 without targeting it for degradation. Ubiquitinates and
CC       promotes degradation of TGFBR1; the ubiquitination is enhanced by
CC       SMAD7. Ubiquitinates SMAD6 and SMAD7. Ubiquitinates and promotes
CC       degradation of SMAD2 in response to TGF-beta signaling, which
CC       requires interaction with TGIF. {ECO:0000269|PubMed:12535537,
CC       ECO:0000269|PubMed:15221015, ECO:0000269|PubMed:15359284}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- ENZYME REGULATION: Activated by NDFIP1- and NDFIP2-binding.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Binds KLF2 AND HIVEP3 (By similarity). Binds SCNN1A,
CC       SCNN1B, SCNN1G, WBP1, WBP2, DRPLA and adenovirus type 2 PIII.
CC       Interacts with RNF11 (By similarity). Interacts with SPG20.
CC       Interacts with ERBB4 isoforms JM-B CYT-1 and JM-A CYT-1. Interacts
CC       with SMAD1, SMAD2, SMAD3, SMAD5, SMAD6, SMAD7, TGFBR1 AND TGFBR2.
CC       Associates with the TGFBR1:TGFBR2 receptor complex in presence of
CC       SMAD7. Interacts with SKIL isoform 1. Interacts with TP63 isoform
CC       1 and isoform 2. Interacts with STAMBP and RNF11. Interacts with
CC       NDFIP1 and NDFIP2 (Probable); this interaction activates the E3
CC       ubiquitin-protein ligase. Interacts with TGIF. {ECO:0000250,
CC       ECO:0000269|PubMed:12450395, ECO:0000269|PubMed:15221015,
CC       ECO:0000269|PubMed:15359284, ECO:0000269|PubMed:19561640,
CC       ECO:0000269|PubMed:19580544, ECO:0000269|PubMed:9169421,
CC       ECO:0000269|PubMed:9647693}.
CC   -!- INTERACTION:
CC       Q8WU02:-; NbExp=3; IntAct=EBI-742157, EBI-747182;
CC       Q16630:CPSF6; NbExp=3; IntAct=EBI-742157, EBI-358410;
CC       Q96D16:FBXL18; NbExp=3; IntAct=EBI-742157, EBI-744419;
CC       P84022:SMAD3; NbExp=8; IntAct=EBI-742157, EBI-347161;
CC       Q9BUZ4:TRAF4; NbExp=3; IntAct=EBI-742157, EBI-3650647;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=A;
CC         IsoId=Q9H0M0-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=Q9H0M0-2; Sequence=VSP_007601, VSP_007603;
CC       Name=3; Synonyms=C;
CC         IsoId=Q9H0M0-3; Sequence=VSP_007602;
CC       Name=4; Synonyms=D;
CC         IsoId=Q9H0M0-4; Sequence=Not described;
CC       Name=5; Synonyms=E;
CC         IsoId=Q9H0M0-5; Sequence=Not described;
CC       Name=6; Synonyms=F;
CC         IsoId=Q9H0M0-6; Sequence=VSP_007600;
CC   -!- TISSUE SPECIFICITY: Detected in heart, placenta, pancreas, kidney,
CC       liver, skeletal muscle, bone marrow, fetal brain, and at much
CC       lower levels in adult brain and lung. Isoform 1 and isoform 5
CC       predominate in all tissues tested, except in testis and bone
CC       marrow, where isoform 5 is expressed at much higher levels than
CC       isoform 1. {ECO:0000269|PubMed:11779188,
CC       ECO:0000269|PubMed:9647693}.
CC   -!- PTM: Auto-ubiquitinated and ubiquitinated by RNF11.
CC       {ECO:0000269|PubMed:15359284, ECO:0000269|PubMed:18724389,
CC       ECO:0000269|PubMed:19343052}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/WWP1ID42993ch8q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136739; CAB66673.1; -; mRNA.
DR   EMBL; AY043361; AAK94668.1; -; mRNA.
DR   EMBL; AY345857; AAQ22764.1; -; mRNA.
DR   EMBL; AC083845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103817; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015380; AAH15380.2; -; mRNA.
DR   EMBL; BC036065; AAH36065.1; -; mRNA.
DR   EMBL; U96113; AAC51324.1; -; mRNA.
DR   CCDS; CCDS6242.1; -. [Q9H0M0-1]
DR   RefSeq; NP_008944.1; NM_007013.3. [Q9H0M0-1]
DR   RefSeq; XP_005250817.1; XM_005250760.3. [Q9H0M0-1]
DR   UniGene; Hs.655189; -.
DR   PDB; 1ND7; X-ray; 2.10 A; A=546-917.
DR   PDB; 2OP7; NMR; -; A=494-532.
DR   PDB; 5HPS; X-ray; 2.05 A; A=537-917.
DR   PDB; 5HPT; X-ray; 2.84 A; A/D/G=537-917.
DR   PDBsum; 1ND7; -.
DR   PDBsum; 2OP7; -.
DR   PDBsum; 5HPS; -.
DR   PDBsum; 5HPT; -.
DR   ProteinModelPortal; Q9H0M0; -.
DR   SMR; Q9H0M0; -.
DR   BioGrid; 116243; 83.
DR   IntAct; Q9H0M0; 36.
DR   MINT; MINT-199541; -.
DR   STRING; 9606.ENSP00000265428; -.
DR   iPTMnet; Q9H0M0; -.
DR   PhosphoSitePlus; Q9H0M0; -.
DR   BioMuta; WWP1; -.
DR   DMDM; 32171908; -.
DR   PaxDb; Q9H0M0; -.
DR   PeptideAtlas; Q9H0M0; -.
DR   PRIDE; Q9H0M0; -.
DR   DNASU; 11059; -.
DR   Ensembl; ENST00000265428; ENSP00000265428; ENSG00000123124. [Q9H0M0-1]
DR   Ensembl; ENST00000517970; ENSP00000427793; ENSG00000123124. [Q9H0M0-1]
DR   GeneID; 11059; -.
DR   KEGG; hsa:11059; -.
DR   UCSC; uc003ydt.4; human. [Q9H0M0-1]
DR   CTD; 11059; -.
DR   DisGeNET; 11059; -.
DR   GeneCards; WWP1; -.
DR   HGNC; HGNC:17004; WWP1.
DR   HPA; HPA023180; -.
DR   MIM; 602307; gene.
DR   neXtProt; NX_Q9H0M0; -.
DR   OpenTargets; ENSG00000123124; -.
DR   PharmGKB; PA134960138; -.
DR   eggNOG; KOG0940; Eukaryota.
DR   eggNOG; COG5021; LUCA.
DR   GeneTree; ENSGT00760000118966; -.
DR   HOGENOM; HOG000208453; -.
DR   HOVERGEN; HBG004134; -.
DR   InParanoid; Q9H0M0; -.
DR   KO; K05633; -.
DR   OMA; LEMYFCV; -.
DR   OrthoDB; EOG091G0SS8; -.
DR   PhylomeDB; Q9H0M0; -.
DR   TreeFam; TF323658; -.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-1253288; Downregulation of ERBB4 signaling.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q9H0M0; -.
DR   SIGNOR; Q9H0M0; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; WWP1; human.
DR   EvolutionaryTrace; Q9H0M0; -.
DR   GeneWiki; WWP1; -.
DR   GenomeRNAi; 11059; -.
DR   PRO; PR:Q9H0M0; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000123124; -.
DR   CleanEx; HS_WWP1; -.
DR   ExpressionAtlas; Q9H0M0; baseline and differential.
DR   Genevisible; Q9H0M0; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000151; C:ubiquitin ligase complex; NAS:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; TAS:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; NAS:UniProtKB.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0046718; P:viral entry into host cell; TAS:UniProtKB.
DR   CDD; cd00078; HECTc; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR024928; E3_ub_ligase_SMURF1.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR001202; WW_dom.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00632; HECT; 1.
DR   Pfam; PF00397; WW; 4.
DR   PIRSF; PIRSF001569; E3_ub_ligase_SMURF1; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00119; HECTc; 1.
DR   SMART; SM00456; WW; 4.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF51045; SSF51045; 4.
DR   SUPFAM; SSF56204; SSF56204; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50237; HECT; 1.
DR   PROSITE; PS01159; WW_DOMAIN_1; 4.
DR   PROSITE; PS50020; WW_DOMAIN_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasm; Host-virus interaction; Membrane; Nucleus; Polymorphism;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1    922       NEDD4-like E3 ubiquitin-protein ligase
FT                                WWP1.
FT                                /FTId=PRO_0000120336.
FT   DOMAIN        5     98       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      349    382       WW 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      381    414       WW 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      456    489       WW 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      496    529       WW 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      588    922       HECT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00104}.
FT   ACT_SITE    890    890       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00104}.
FT   SITE        890    890       Required for ubiquitin-thioester
FT                                formation. {ECO:0000250}.
FT   VAR_SEQ      23    240       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:11779188}.
FT                                /FTId=VSP_007600.
FT   VAR_SEQ     112    242       LERVKEQLKLSLENKNGIAQTGELTVVLDGLVIEQENITNC
FT                                SSSPTIEIQENGDALHENGEPSARTTARLAVEGTNGIDNHV
FT                                PTSTLVQNSCCSYVVNGDNTPSSPSQVAARPKNTPAPKPLA
FT                                SEPADDTV -> F (in isoform 3).
FT                                {ECO:0000303|PubMed:11779188}.
FT                                /FTId=VSP_007602.
FT   VAR_SEQ     112    120       LERVKEQLK -> CWLLKARME (in isoform 2).
FT                                {ECO:0000303|PubMed:11779188}.
FT                                /FTId=VSP_007601.
FT   VAR_SEQ     121    922       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11779188}.
FT                                /FTId=VSP_007603.
FT   VARIANT     852    852       G -> V (in dbSNP:rs1059901).
FT                                /FTId=VAR_052960.
FT   MUTAGEN     614    614       E->A: Reduces ubiquitin transfer.
FT                                {ECO:0000269|PubMed:12535537}.
FT   MUTAGEN     621    621       H->A: Strongly reduces ubiquitin
FT                                transfer. {ECO:0000269|PubMed:12535537}.
FT   MUTAGEN     675    675       D->A: Reduces ubiquitin transfer.
FT                                {ECO:0000269|PubMed:12535537}.
FT   MUTAGEN     798    798       E->A: Reduces ubiquitin transfer.
FT                                Strongly reduces ubiquitin transfer; when
FT                                associated with A-845.
FT                                {ECO:0000269|PubMed:12535537}.
FT   MUTAGEN     804    804       M->P: Strongly reduces ubiquitin
FT                                transfer; when associated with P-806.
FT                                {ECO:0000269|PubMed:12535537}.
FT   MUTAGEN     806    806       E->P: Strongly reduces ubiquitin
FT                                transfer; when associated with P-804.
FT                                {ECO:0000269|PubMed:12535537}.
FT   MUTAGEN     845    845       R->A: No effect.
FT                                {ECO:0000269|PubMed:12535537}.
FT   MUTAGEN     848    848       Q->A: Abolishes ubiquitin transfer; when
FT                                associated with A-855.
FT                                {ECO:0000269|PubMed:12535537}.
FT   MUTAGEN     855    855       R->A: Abolishes ubiquitin transfer; when
FT                                associated with A-848.
FT                                {ECO:0000269|PubMed:12535537}.
FT   STRAND      500    505       {ECO:0000244|PDB:2OP7}.
FT   TURN        509    511       {ECO:0000244|PDB:2OP7}.
FT   STRAND      513    518       {ECO:0000244|PDB:2OP7}.
FT   STRAND      521    523       {ECO:0000244|PDB:2OP7}.
FT   HELIX       547    559       {ECO:0000244|PDB:5HPS}.
FT   STRAND      564    571       {ECO:0000244|PDB:5HPS}.
FT   TURN        573    575       {ECO:0000244|PDB:1ND7}.
FT   HELIX       576    586       {ECO:0000244|PDB:5HPS}.
FT   HELIX       589    593       {ECO:0000244|PDB:5HPS}.
FT   STRAND      594    600       {ECO:0000244|PDB:5HPS}.
FT   TURN        601    603       {ECO:0000244|PDB:1ND7}.
FT   HELIX       611    623       {ECO:0000244|PDB:5HPS}.
FT   HELIX       626    628       {ECO:0000244|PDB:5HPS}.
FT   STRAND      629    636       {ECO:0000244|PDB:5HPS}.
FT   STRAND      641    643       {ECO:0000244|PDB:5HPS}.
FT   HELIX       645    649       {ECO:0000244|PDB:5HPS}.
FT   HELIX       653    669       {ECO:0000244|PDB:5HPS}.
FT   HELIX       680    686       {ECO:0000244|PDB:5HPS}.
FT   HELIX       693    699       {ECO:0000244|PDB:5HPS}.
FT   HELIX       701    712       {ECO:0000244|PDB:5HPS}.
FT   HELIX       715    718       {ECO:0000244|PDB:5HPS}.
FT   STRAND      723    730       {ECO:0000244|PDB:5HPS}.
FT   STRAND      733    740       {ECO:0000244|PDB:5HPS}.
FT   HELIX       743    745       {ECO:0000244|PDB:1ND7}.
FT   TURN        749    751       {ECO:0000244|PDB:5HPS}.
FT   HELIX       752    765       {ECO:0000244|PDB:5HPS}.
FT   TURN        766    769       {ECO:0000244|PDB:5HPS}.
FT   HELIX       770    783       {ECO:0000244|PDB:5HPS}.
FT   HELIX       786    791       {ECO:0000244|PDB:5HPS}.
FT   HELIX       794    802       {ECO:0000244|PDB:5HPS}.
FT   HELIX       809    814       {ECO:0000244|PDB:5HPS}.
FT   STRAND      817    820       {ECO:0000244|PDB:5HPS}.
FT   HELIX       826    837       {ECO:0000244|PDB:5HPS}.
FT   HELIX       840    851       {ECO:0000244|PDB:5HPS}.
FT   HELIX       860    863       {ECO:0000244|PDB:5HPS}.
FT   STRAND      867    870       {ECO:0000244|PDB:5HPT}.
FT   STRAND      874    876       {ECO:0000244|PDB:5HPS}.
FT   STRAND      881    883       {ECO:0000244|PDB:5HPT}.
FT   STRAND      886    888       {ECO:0000244|PDB:5HPS}.
FT   HELIX       889    891       {ECO:0000244|PDB:5HPS}.
FT   STRAND      893    895       {ECO:0000244|PDB:5HPS}.
FT   HELIX       902    914       {ECO:0000244|PDB:5HPS}.
SQ   SEQUENCE   922 AA;  105202 MW;  35B6E1C03A3147DA CRC64;
     MATASPRSDT SNNHSGRLQL QVTVSSAKLK RKKNWFGTAI YTEVVVDGEI TKTAKSSSSS
     NPKWDEQLTV NVTPQTTLEF QVWSHRTLKA DALLGKATID LKQALLIHNR KLERVKEQLK
     LSLENKNGIA QTGELTVVLD GLVIEQENIT NCSSSPTIEI QENGDALHEN GEPSARTTAR
     LAVEGTNGID NHVPTSTLVQ NSCCSYVVNG DNTPSSPSQV AARPKNTPAP KPLASEPADD
     TVNGESSSFA PTDNASVTGT PVVSEENALS PNCTSTTVED PPVQEILTSS ENNECIPSTS
     AELESEARSI LEPDTSNSRS SSAFEAAKSR QPDGCMDPVR QQSGNANTET LPSGWEQRKD
     PHGRTYYVDH NTRTTTWERP QPLPPGWERR VDDRRRVYYV DHNTRTTTWQ RPTMESVRNF
     EQWQSQRNQL QGAMQQFNQR YLYSASMLAA ENDPYGPLPP GWEKRVDSTD RVYFVNHNTK
     TTQWEDPRTQ GLQNEEPLPE GWEIRYTREG VRYFVDHNTR TTTFKDPRNG KSSVTKGGPQ
     IAYERGFRWK LAHFRYLCQS NALPSHVKIN VSRQTLFEDS FQQIMALKPY DLRRRLYVIF
     RGEEGLDYGG LAREWFFLLS HEVLNPMYCL FEYAGKNNYC LQINPASTIN PDHLSYFCFI
     GRFIAMALFH GKFIDTGFSL PFYKRMLSKK LTIKDLESID TEFYNSLIWI RDNNIEECGL
     EMYFSVDMEI LGKVTSHDLK LGGSNILVTE ENKDEYIGLM TEWRFSRGVQ EQTKAFLDGF
     NEVVPLQWLQ YFDEKELEVM LCGMQEVDLA DWQRNTVYRH YTRNSKQIIW FWQFVKETDN
     EVRMRLLQFV TGTCRLPLGG FAELMGSNGP QKFCIEKVGK DTWLPRSHTC FNRLDLPPYK
     SYEQLKEKLL FAIEETEGFG QE
//
